141st APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

293189
Global health begins at home


Monday, November 4, 2013 : 8:30 a.m. - 8:35 a.m.

Richard Derman, MD MPH, Dept. of Obstetrics & Gynecology, Christiana Care Health System, Newark, DE
     
According to estimates of the World Health Organization, the World Bank, and other international organizations, the United States ranked 47th for its maternal mortality ratio (of 21 maternal deaths per 100,000 live births, 2010). Likewise, the US ranked 47th (along with two other countries) for its 2011neonatal mortality rate (of 4.3 neonatal deaths per 1,000 live births). Despite huge expenditure of resources, we continue to see an increase in adverse outcomes - - disproportionate among disparate populations.

We will describe parallels in adverse outcomes between the US and other developing countries, and focus on the leading causes of mortality and morbidity citing programs to address the issue.

Learning Areas:

Administer health education strategies, interventions and programs
Clinical medicine applied in public health
Epidemiology
Planning of health education strategies, interventions, and programs
Public health or related research

Learning Objectives:
Describe parallels in adverse outcomes between the US and other developing countries Discuss the leading causes of mortality and morbidity citing programs to address the issue Demonstrate the impact of disparities in maternal/neonatal outcomes

Keyword(s): Maternal Health, Infant Mortality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Previous experience serving as panel chair for MCH
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3043.0: International Maternal, Neonatal & Child Health